Skip to main content
. 2015 Sep 15;5(10):3270–3275.

Table 2.

Disease control rates of 62 Chinese patients with advanced NSCLC and 2nd-line chemotherapy of nintedanib

Disease control rates Number Percentage
C.R. 0 0.0%
P.R. 23 37.1%
S.D. 31 50.0%
D.P. 8 8.1%

Abbreviations: C.R., complete response; P.R., partial response; S.D., stable disease; D.P., disease progression.